MedTrace Logo

Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.

NCT03470857 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2022-09-28

No results posted yet for this study

Summary

The research aims to determine the parameters of oxidative stress and inflammatory processes and compare these parameters with the image obtained using positron emission tomography (PET) with 2-deoxy-2-\[fluorine-18\]fluoro- D-glucose (18F-FDG) integrated with computed tomography (CT) in the group of oncological patients.

Conditions

  • Neoplasms
  • Antioxidants
  • Oxidative Stress
  • Lipid Peroxidation
  • Inflammation
  • Lysosome Alteration

Interventions

DIAGNOSTIC_TEST

Patients

The FDG PET/CT imaging will be performed as part of typical medical procedures related to the diagnosis and monitoring of cancers at the Oncology Center in Bydgoszcz, Poland

Sponsors & Collaborators

  • Nicolaus Copernicus University

    lead OTHER

Principal Investigators

  • Paweł Sutkowy, PhD · The Chair of Medical Biology, Collegium Medicum of Nicolaus Copernicus University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470857 on ClinicalTrials.gov